FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / ...

ABL Advisor Search Results

News Stories (19 Results) - Pharmaceuticals

According to an article authored by Michael Gibney, Healthcare Reporter, S&P Global Market Intelligence and published by S&P Global Market Intelligence on June 15, 2020, for some biotech and pharmaceutical companies ready to send new drugs out into... Read Story
June 15, 2020, 09:10 AM


Facing nearly 2,000 lawsuits for its alleged role in facilitating America’s overdose crisis, Purdue Pharma – maker of the narcotic painkiller OxyContin – is reportedly considering filing for Chapter 11 bankruptcy, according to sources cited by... Read Story
March 06, 2019, 08:23 AM


Recro Pharma, Inc., a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care settings, announced that it has closed on an amended and expanded $125 million credit facility with investment funds... Read Story
March 04, 2019, 07:11 AM


Bristol-Myers Squibb Company and Burgundy Merger Sub, Inc., a wholly owned subsidiary of BMS, entered into an Agreement and Plan of Merger with Celgene Corporation (Celgene). The Merger Agreement provides, among other things, that on the terms and... Read Story
January 04, 2019, 09:00 AM


ANI Pharmaceuticals, Inc. announced that it has entered an amended and restated five-year Senior Secured Credit Facility for up to $265.2 million with its existing syndicate of bank lenders. The Facility amends ANI's current $125 million Senior... Read Story
December 28, 2018, 08:32 AM


Capital One announced  that it served as administrative agent and lead arranger for a $350 million senior credit facility for Covis Pharma B.V. (Covis). The facility consists of a $25 million revolver and a $325 million term loan that Covis used to... Read Story
December 13, 2018, 07:15 AM


Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new nausea & vomiting treatments for surgical and cancer patients, has secured a credit facility of up to $30 million with Hercules... Read Story
July 02, 2018, 07:16 AM


pSivida Corp., a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced the acquisition of Icon Bioscience Inc. (Icon). Icon is a specialty biopharmaceutical company whose lead... Read Story
April 02, 2018, 07:10 AM


Charles River Laboratories International, Inc. announced that it has refinanced its existing $1.0 billion of revolving credit facility due 2021 with a new $1.55 billion revolving credit facility due 2023, and its existing $650.0 million of term loan... Read Story
March 26, 2018, 07:22 AM


Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, announced that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware... Read Story
March 12, 2018, 07:51 AM


Mallinckrodt has entered into a $600 million senior secured term loan facility to help finance its merger with Sucampo Pharmaceuticals, Inc., according to a regulatory filing. The New Term Loan is an incremental facility under the Credit Agreement... Read Story
February 14, 2018, 07:15 AM


Super G announced the company provided a $2.0 million senior secured, interest-only bridge loan for a private equity backed, outsourced pharmaceutical service provider conducting clinical research. The senior secured, interest-only bridge loan was... Read Story
January 25, 2018, 07:03 AM


Pharmaceutical Research Associates, Inc., a Virginia corporation (PRA) and a wholly-owned subsidiary of PRA Health Sciences, Inc., entered into a First Amendment and Second Joinder Agreement to the Credit Agreement, dated as of December 6, 2016 with... Read Story
January 02, 2018, 07:00 AM


Recro Pharma, Inc., a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, announced that it has secured a $100 million credit facility from funds managed by Athyrium Capital... Read Story
November 21, 2017, 07:09 AM


Emergent BioSolutions Inc. announced that it has completed a new five-year, $200 million syndicated senior secured credit facility. This new facility replaces and represents an increase from the company's prior $100 million facility, which was... Read Story
October 02, 2017, 08:00 AM


Teva Pharmaceutical Industries Ltd., announced amendments to its USD and JPY term loan and revolving credit facilities, providing Teva greater flexibility in its financial leverage ratio covenants. The amended leverage ratio covenants in the credit... Read Story
September 20, 2017, 07:10 AM


Synergy Pharmaceuticals Inc. announced that the company has closed on a $300 million debt financing structured as senior secured loans from CRG LP, a healthcare focused investment firm, and its lender syndicate.“This non-dilutive financing enhances... Read Story
September 06, 2017, 07:09 AM


Heska Corporation announced that it has entered into a new $30 million credit agreement with JPMorgan Chase, Inc. The credit agreement matures in July 2020 and replaces the Company's existing $15 million asset based line of credit. The new facility... Read Story
July 28, 2017, 07:08 AM


Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that it has entered into a $50 million senior... Read Story
July 17, 2017, 07:17 AM